References
- Portman DJ, Gass ML. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Maturitas 2014;79:349–54
- Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc 2010; 85:87–94
- North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause 2007;14:355–69
- Palma F, Volpe A, Villa P, Cagnacci A. Writing Group of AGATA study. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: the AGATA study. Maturitas 2016;83:40–4
- Palacios S, Nappi RE, Bruyniks N, Particco M, Panay N. The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause. Climacteric 2018;21:286–91
- Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA)—Results from an international survey. Climacteric 2012;15:36–44
- Cagnacci A, Carbone MM, Palma P. as the writing group of the AGATA study. Prevalence and association between objective signs and subjective symptoms of vaginal atrophy: the AGATA study. Menopause 2016;23:1139–45
- Palma F, Xholli A, Cagnacci A. as the writing group of the AGATA study. The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study. Maturitas 2018;108:18–23
- Caruso S, Cianci A, Amore FF, et al. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel. Menopause 2016;23:47–54
- Simon JA, Nappi RE, Kingsberg SA, Maamari R, Brown V. Clarifying Vaginal Atrophy's Impact on Sex and Relationships (CLOSER) survey: emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners. Menopause 2014;21:137–42
- Levine KE, Williams RE, Hartmann KE. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause 2008;15:661–6
- Nappi RE, Particco M, Biglia N, et al. Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: evidence from the European REVIVE survey. Maturitas 2016;91:74–80
- Nicolosi A, Laumann EO, Glasser DB, Moreira ED, Paik A, Gingell C. Study of Sexual Attitudes and Behaviors Investigators’ Group: sexual beahvior and sexual dysfunction after age 40: the global study of sexual attitudes and behaviors. Urology 2004;64:991–7
- Lindau ST, Schumm LP, Laumann EO, Levinson W, O'Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med 2007;357:762–74
- Gass ML, Cochrane BB, Larson JC, et al. Patterns and predictors of sexual activity among women in the hormone therapy trials of the Women’s Health Initiative. Menopause 2011;18:1160–71
- Nappi RE, Mattsson L-A, Lachowsky M, Maamari R, Giraldi A. The CLOSER survey: Impact of postmenopausal vaginal discomfort on relationships between women and their partners in Northern and Souithern Europe. Maturitas 2013;75:73–9
- Moral E, Delgado JL, Carmona F, as the writing group of the GENISSE study, et al. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study. Climacteric 2018;21:167–73
- Cagnacci A, Pansini FS, Bacchi-Modena A, for the Emilia-Romagna Operative Group for the Menopause (GOERM), et al. Season of birth influences the timing of menopause. Hum Reprod 2005;20:2190–3
- Montserrat García-Closas M, Herrero R, Bratti C, et al. Epidemiologic determinants of vaginal pH. Am J Obstet Gynecol 1999;180:1060–6
- Pfizer Pharmaceuticals, Inc. Healthy women survey. Available at: http://www.personalmenopauseanswers.com/healthywomen-survey.aspx (accessed August 11, 2012)
- Nappi RE, Palacios S, Panay N, Particco M, Krychman ML. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric 2016;19:188–97
- Mishra GD, Kuh D. Health symptoms during midlife in relation to menopausal transition: British prospective cohort study. BMJ 2012;344:e402
- Nappi RE, Kingsberg S, Maamari R, Simon J. The CLOSER (CLarifying Vaginal Atrophy's Impact On SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners. J Sex Med 2013;10:2232–41
- Roy S, Caillouette JC, Roy T, Faden JS. Vaginal pH is similar to follicle-stimulating hormone for menopausal diagnosis. Am J Obstet Gynecol 2004;190:1272–7